An In Vivo Model to Study Shear-Dependent Bacterial Adhesion
JoVE Encyclopedia of Experiments
Microbiology
0 views • 3:50 min • July 1st, 2026
Loading...
Overview
This article presents a detailed in vivo protocol for studying shear-dependent bacterial adhesion to the vessel wall in a live mouse model. The method combines surgical preparation, catheterization, and real-time fluorescence imaging to visualize and quantify the interactions between von Willebrand factor (VWF) and bacteria under physiological flow conditions.
Key Study Components
Area of Science
- Microbiology
- Vascular biology
- In vivo imaging
Background
- Bacterial adhesion to blood vessel walls is a critical step in the pathogenesis of bloodstream infections.
- Shear stress from blood flow influences the interaction between bacteria and endothelial surfaces.
- von Willebrand factor (VWF) is released from endothelial cells and plays a role in mediating bacterial aggregation under flow.
- Real-time imaging in live animals provides insights into these dynamic processes.
Purpose of Study
- To establish an in vivo model for analyzing bacterial adhesion to vessel walls under flow conditions.
- To visualize the formation of VWF strands and their interaction with bacteria in real time.
- To quantify shear-dependent bacterial aggregation on endothelial surfaces.
Methods Used
- Overnight fasting and anesthesia of mice to prepare for surgery.
- Surgical exposure and catheterization of the right jugular vein.
- Exposure of the mesenteric vasculature via abdominal incision and placement on a transparent plate.
- Topical application of a calcium ionophore to induce VWF release from endothelial cells.
- Injection of fluorescently labeled bacteria through the catheter.
- Real-time fluorescence microscopy and time-lapse image acquisition.
- Image analysis using ImageJ software.
Main Results
- Calcium ionophore application triggers VWF strand formation on endothelial surfaces.
- Shear stress from blood flow uncoils VWF strands, facilitating bacterial binding and aggregation.
- Fluorescent imaging enables visualization and quantification of bacterial adhesion events.
- The protocol allows for controlled study of shear-dependent bacterial-endothelial interactions in vivo.
Conclusions
- This in vivo model effectively demonstrates the role of shear stress and VWF in bacterial adhesion to vessel walls.
- The approach provides a platform for studying host-pathogen interactions under physiological flow conditions.
- It can be adapted for investigating mechanisms of vascular infection and evaluating potential therapeutic interventions.
Frequently Asked Questions
What is the main advantage of using this in vivo model?
It allows real-time visualization and quantification of bacterial adhesion to vessel walls under physiological flow conditions, closely mimicking in vivo environments.
Why is a calcium ionophore used in this protocol?
The calcium ionophore elevates intracellular calcium in endothelial cells, triggering the release of von Willebrand factor (VWF) strands that mediate bacterial adhesion.
How are bacteria visualized during the experiment?
Bacteria are fluorescently labeled prior to injection, enabling their detection and tracking using fluorescence microscopy.
What role does shear stress play in this model?
Shear stress from blood flow uncoils VWF strands, exposing binding sites for bacterial adhesins and promoting aggregation on the vessel wall.
How is image data analyzed after acquisition?
Time-lapse images are processed and quantified using ImageJ analysis software to assess bacterial adhesion events.
Can this protocol be adapted for other pathogens or conditions?
Yes, the model can be modified to study different bacterial strains or to investigate the effects of various interventions on vascular adhesion.
Executive Industry Relevance
Shear-dependent bacterial adhesion is a critical factor in vascular infection pathogenesis and impacts early-stage target validation for anti-adhesion therapeutics. This in vivo model enables real-time quantification of bacterial-endothelial interactions under physiological flow, supporting predictive confidence in mechanistic de-risking. The approach informs portfolio decisions by clarifying host-pathogen dynamics relevant to preclinical infectious disease research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of bacterial adhesion mechanisms under physiological shear stress.
- Supports functional validation of targets such as von Willebrand factor in host-pathogen interactions.
- Provides mechanistic de-risking for anti-adhesion therapeutic strategies.
- Facilitates predictive confidence in early-stage infectious disease models.
Screening & Assay Development
- Establishes a validated in vivo system for quantifying bacterial adhesion events.
- Delivers reproducible, quantitative imaging outputs for downstream analysis.
- Supports assay standardization for evaluating candidate interventions targeting adhesion pathways.
- Enables reliable comparison of bacterial strains or therapeutic effects under controlled flow conditions.
Translational & Preclinical Research
- Aligns with disease-relevant vascular infection models for translational biomarker exploration.
- Provides continuity from discovery-stage mechanistic studies to preclinical validation of anti-adhesion agents.
- Informs risk-adjusted advancement decisions for infectious disease portfolios.
- Supports mechanistic de-risking in the context of vascular infection pathogenesis.
Pipeline & Workflow Integration
This in vivo imaging model bridges early discovery and preclinical research by enabling hypothesis-driven interrogation of bacterial adhesion under flow.
- Discovery Biology: Clarifies the role of shear stress and VWF in bacterial adhesion, supporting hypothesis testing and biological de-risking.
- Screening: Provides quantitative, reproducible imaging outputs for assay development and candidate evaluation.
- Analytics: Generates time-lapse image data for robust statistical comparison of adhesion events across conditions.
- Translational Research: Connects mechanistic findings to disease-relevant vascular infection models.
- Enterprise Reuse: Offers a reusable platform adaptable to various bacterial strains and intervention studies.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence and target validation for anti-adhesion strategies.
- Operational Value: Delivers standardized, reproducible, and scalable in vivo imaging workflows.
- Strategic Value: Improves go/no-go decisions and reduces late-stage biological risk in infectious disease programs.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of anti-adhesion therapeutics.
Implementation Considerations
- Requires expertise in small animal surgery and in vivo imaging techniques.
- Demands access to fluorescence microscopy and quantitative image analysis infrastructure.
- Necessitates cross-team standardization for reproducible data acquisition and analysis.
- Adaptable to different bacterial strains and intervention modalities with protocol optimization.
- Limited to vascular beds accessible for imaging and may require model-specific adjustments.
Biopharma FAQs
Why does null hypothesis testing matter for shear-dependent adhesion quantification?
Null hypothesis testing enables objective assessment of whether observed bacterial adhesion under flow differs significantly from baseline or control conditions, supporting robust target validation and mechanistic de-risking.
How does independent variable isolation fit the in vivo VWF activation workflow?
Isolating variables such as calcium ionophore application allows precise attribution of VWF strand formation and bacterial aggregation to specific triggers, clarifying mechanistic pathways in the discovery pipeline.
What do quantitative time-lapse image measurements enable in this model?
Quantitative time-lapse imaging provides reproducible metrics of bacterial adhesion events, enabling statistical comparison across experimental groups and supporting data-driven advancement decisions.
Why are replication requirements critical for cross-functional infectious disease teams?
Replication ensures that observed adhesion phenomena are robust and reproducible, facilitating cross-team confidence in data and supporting collaborative assay development and validation efforts.
Which statistical analysis capabilities are required before implementing image-based adhesion quantification?
Teams must establish workflows for processing and analyzing time-lapse images, including thresholding, event counting, and statistical comparison, to ensure reliable and actionable outputs for R&D decision-making.
08:50
Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
Related Videos
0 Views
07:50
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Related Videos
0 Views
09:34
Pneumococcus Infection of Primary Human Endothelial Cells in Constant Flow
Related Videos
0 Views
05:57
In Vitro Assay of Bacterial Adhesion onto Mammalian Epithelial Cells
Related Videos
0 Views
13:28
Introducing Shear Stress in the Study of Bacterial Adhesion
Related Videos
0 Views
02:47
In Vitro Parallel-Plate Flow Model to Study Bacterial Adhesion on a Tissue Biopsy
Related Videos
0 Views
02:44
In Vitro Gut Model to Assess Bacterial Adhesion and Internalization
Related Videos
0 Views
03:10
Micro-Parallel Plate Flow Chamber Model for Studying Bacterial Adhesion to Human Endothelial Cells
Related Videos
0 Views
09:52
Generation of Shear Adhesion Map Using SynVivo Synthetic Microvascular Networks
Related Videos
0 Views
10:24
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
Related Videos
0 Views
Last updated: 22 August 2026